Genome-wide miRNAs expression profiles of Schistosoma japonicum schistosomula in response to artesunate

Reference

• 1 Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet 383, 2253–2264 (2014).
  MedlineGoogle Scholar
• 2 King CH. Parasites and poverty: the case of schistosomiasis. Acta Trop. 113, 95–104 (2010).
  MedlineGoogle Scholar
• 3 Gray DJ, McManus DP, Li Y, Williams GM, Bergquist R, Ross AG. Schistosomiasis elimination: lessons from the past guide the future. Lancet Infect. Dis. 10, 733–736 (2010).
  MedlineGoogle Scholar
• 4 Wu W, Huang Y. Application of praziquantel in schistosomiasis japonica control strategies in China. Parasitol. Res. 112, 909–915 (2013).
  MedlineGoogle Scholar
• 5 Doenhoff MJ, Pica-Mattoccia L. Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance. Expert Rev. Anti-infecti. Ther. 4, 199–210 (2006).
  Medline CASGoogle Scholar
• 6 Xiao SH, Keiser J, Chen MG et al. Research and development of antischistosomal drugs in the People’s Republic of China a 60-year review. Adv. Parasitol. 73, 231–295 (2010).
  MedlineGoogle Scholar
• 7 Xiao SH. Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins. Acta Trop. 96, 153–167 (2005).
  Medline CASGoogle Scholar
• 8 Wang W, Wang L, Liang YS. Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitol. Res. 111, 1871–1877 (2012).
  MedlineGoogle Scholar
• 9 Utzinger J, N’Goran EK, N’Dri A, Lengeler C, Xiao S, Tanner M. Oral artemether for prevention of Schistosoma mansoni infection. randomised controlled trial. Lancet 355, 1320–1325 (2000).
  Medline CASGoogle Scholar
• 10 Utzinger J, Keiser J, Shuhua X, Tanner M, Singer BH. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob. Agents Chemother. 47, 1487–1495 (2003).
  Medline CASGoogle Scholar
• 11 Li S, Wu L, Liu Z et al. Studies on prophylactic effect of artesunate on schistosomiasis japonica. Chin. Med. J. (Engl.) 109, 848–853 (1996).
  Medline CASGoogle Scholar
• 12 Hua HY, Liang YS, Zhang Y, Wei JF, Guo HX. The sensitivity of artesunate against Schistosoma japonicum decreased after 10 years of use in China. Parasitol. Res. 107, 873–878 (2010).
  MedlineGoogle Scholar
• 13 Cui Land, Su XZ. Discovery, mechanisms of action and combination therapy of artemisinin. Expert Rev. Anti-infecti. Ther. 7, 999–1013 (2009).
  Medline CASGoogle Scholar
• 14 You J, Guo H, Mei J et al. [Effect of artemether on glycogen, protein, alkaline phosphatase and acid phosphatase of Schistosoma japonicum]. Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi 12, 275–278 (1994).
  Medline CASGoogle Scholar
• 15 Krishna S, Pulcini S, Fatih F, Staines H. Artemisinins and the biological basis for the PfATP6/SERCA hypothesis. Trends Parasitol. 26, 517–523 (2010).
  Medline CASGoogle Scholar
• 16 Xiao SH, You JQ, Guo HF et al. Effect of artemether on phosphorylase, lactate dehydrogenase, adenosine triphosphatase, and glucosephosphate dehydrogenase of Schistosoma japonicum harbored in mice. Acta Pharmacol. Sin. 20, 750–754 (1999).
  CASGoogle Scholar
• 17 Xiao SH, You JQ, Guo HF et al. Effect of artemether on glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate kinase, and pyruvate kinase of Schistosomajaponicum harbored in mice. Acta Pharmacol. Sin. 19, 279–281 (1998).
  CASGoogle Scholar
• 18 Xiao SH, You JQ, Gao HF et al. Schistosoma japonicum: effect of artemether on glutathione S-transferase and superoxide dismutase. Exp. Parasitol. 102, 38–45 (2002).
  Medline CASGoogle Scholar
• 19 Berman PA, Adams PA. Artemisinin enhances heme-catalysed oxidation of lipid membranes. Free Rad. Biol. Med. 22, 1283–1288 (1997).
  Medline CASGoogle Scholar
• 20 Kong Q, Tong Q, Lou D et al. Quantitative proteomic analyses of Schistosoma japonicum in response to artesunate. Mol. BioSyst. 11, 1400–1409 (2015).
  Medline CASGoogle Scholar
• 21 Filipowicz W, Jaskiewicz L, Kolb FA, Pillai RS. Post-transcriptional gene silencing by siRNAs and miRNAs. Curr. Opin. Struct. Biol. 15, 331–341 (2005).
  Medline CASGoogle Scholar
• 22 Bartel DP. MicroRNAs. genomics, biogenesis, mechanism, and function. Cell. 116, 281–297 (2004).
  Medline CASGoogle Scholar
• 23 Rukov JL, Wilentzik R, Jaffe I, Vinther J, Shomron N. Pharmaco-miR: linking microRNAs and drug effects. Brief. Bioinform. 15, 648–659 (2014).
  Medline CASGoogle Scholar
• 24 Cai P, Hou N, Piao X et al. Profiles of small non-coding RNAs in Schistosoma japonicum during development. PLoS Negl. Trop. Dis. 5, e1256 (2011).
  Medline CASGoogle Scholar
• 25 Sun J, Wang S, Li C, Ren Y, Wang J. Novel expression profiles of microRNAs suggest that specific miRNAs regulate gene expression for the sexual maturation of female Schistosoma japonicum after pairing. Parasit. Vectors 7, 177 (2014).
  MedlineGoogle Scholar
• 26 Marco A, Kozomara A, Hui JH et al. Sex-biased expression of microRNAs in Schistosoma mansoni. PLoS Negl. Trop. Dis. 7, e2402 (2013).
  MedlineGoogle Scholar
• 27 Zhu D, He X, Duan Y et al. Expression of microRNA-454 in TGF-beta1-stimulated hepatic stellate cells and in mouse livers infected with Schistosoma japonicum. Parasit. Vectors 7, 148 (2014).
  MedlineGoogle Scholar
• 28 He X, Sai X, Chen C et al. Host serum miR-223 is a potential new biomarker for Schistosoma japonicum infection and the response to chemotherapy. Parasit. Vectors 6, 272 (2013).
  MedlineGoogle Scholar
• 29 Hoy AM, Lundie RJ, Ivens A et al. Parasite-derived microRNAs in host serum as novel biomarkers of helminth infection. PLoS Negl. Trop. Dis. 8, e2701 (2014).
  MedlineGoogle Scholar
• 30 Cheng G, Luo R, Hu C, Cao J, Jin Y. Deep sequencing-based identification of pathogen-specific microRNAs in the plasma of rabbits infected with Schistosoma japonicum. Parasitology 140, 1751–1761 (2013).
  Medline CASGoogle Scholar
• 31 Prasopdee S, Sotillo J, Tesana S et al. RNA-Seq reveals infection-induced gene expression changes in the snail intermediate host of the carcinogenic liver fluke, Opisthorchis viverrini. PLoS Negl. Trop. Dis. 8(3), e2765 (2014)
  MedlineGoogle Scholar
• 32 Huang J, Hao P, Chen H et al. Genome-wide identification of Schistosoma japonicum microRNAs using a deep-sequencing approach. PLoS ONE 4, e8206 (2009).
  MedlineGoogle Scholar
• 33 Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10(3), R25 (2009).
  MedlineGoogle Scholar
• 34 Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucl. Acids Res. 36, D154–D158 (2008).
  Medline CASGoogle Scholar
• 35 The RNA Institute. http://unafold.rna.albany.edu/?q=mfold/download-mfold
  Google Scholar
• 36 RNAfold WebServer. http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi
  Google Scholar
• 37 Guerra-Assuncao JA, Enright AJ. MapMi. automated mapping of microRNA loci. BMC Bioinformatics 11, 133 (2010).
  MedlineGoogle Scholar
• 38 Wang X, Gardiner EJ, Cairns MJ. Optimal consistency in microRNA expression analysis using reference-gene-based normalization. Mol. BioSyst. 11(5), 1235–1240 (2015).
  Medline CASGoogle Scholar
• 39 D’Haene B, Mestdagh P, Hellemans J, Vandesompele J. miRNA expression profiling: from reference genes to global mean normalization. Methods Mol. Biol. 822, 261–272 (2012).
  MedlineGoogle Scholar
• 40 Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120(1), 15–20 (2005).
  Medline CASGoogle Scholar
• 41 Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Re. 19(1), 92–105 (2009).
  Medline CASGoogle Scholar
• 42 Betel D, Koppal A, Agius P, Sander C, Leslie C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol. 11(8), R90 (2010)
  MedlineGoogle Scholar
• 43 Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools. paths toward the comprehensive functional analysis of large gene lists. Nucl. Acids Res. 37, 1–13 (2009).
  MedlineGoogle Scholar
• 44 Noble WS. How does multiple testing correction work? Nat. Biotechnol. 27(12), 1135–1137 (2009)
  Medline CASGoogle Scholar
• 45 Chen C, Ridzon DA, Broomer AJ et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucl. Acids Res. 33, e179 (2005).
  MedlineGoogle Scholar
• 46 He Y, Chevillet JR, Liu G, Kim TK, Wang K. The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs. Br. J. Pharmacol. 172(11), 2733–2747 (2014).
  MedlineGoogle Scholar
• 47 Carthew RW. Molecular biology. A new RNA dimension to genome control. Science 313, 305–306 (2006).
  MedlineGoogle Scholar
• 48 Zhou Y, Zheng H, Chen Y et al. The Schistosoma japonicum genome reveals features of host-parasite interplay. Nature 460, 345–351 (2009).
  Medline CASGoogle Scholar
• 49 Guengerich FP. Cytochrome p450 and chemical toxicology. Chem. Res. Toxicol. 21, 70–83 (2008).
  Medline CASGoogle Scholar
• 50 Mohri T, Nakajima M, Takagi S, Komagata S, Yokoi T. MicroRNA regulates human vitamin D receptor. Int. J. Cancer 125, 1328–1333 (2009).
  Medline CASGoogle Scholar
• 51 Komagata S, Nakajima M, Takagi S, Mohri T, Taniya T, Yokoi T. Human CYP24 catalyzing the inactivation of calcitriol is post-transcriptionally regulated by miR-125b. Mol. Pharmacol. 76, 702–709 (2009).
  Medline CASGoogle Scholar
• 52 Tili E, Michaille JJ, Luo Z et al. The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. Blood 120, 2631–2638 (2012).
  Medline CASGoogle Scholar
• 53 Pastore A, Federici G, Bertini E, Piemonte F. Analysis of glutathione. implication in redox and detoxification. Clin. Chim. Acta 333, 19–39 (2003).
  Medline CASGoogle Scholar
• 54 Abdin AA, Ashour DS, Shoheib ZS. Artesunate effect on schistosome thioredoxin glutathione reductase and cytochrome c peroxidase as new molecular targets in Schistosoma mansoni-infected mice. Biomed. Environ. Sci. 26, 953–961 (2013).
  Medline CASGoogle Scholar
• 55 Kannan R, Sahal D, Chauhan VS. Heme-artemisinin adducts are crucial mediators of the ability of artemisinin to inhibit heme polymerization. Chem. Biol. 9, 321–332 (2002).
  Medline CASGoogle Scholar
• 56 Wang Z, Xue X, Sun J et al. An “in-depth” description of the small non-coding RNA population of Schistosoma japonicum schistosomulum. PLoS Negl. Trop. Dis. 4, e596 (2010).
  MedlineGoogle Scholar
• 57 Hao L, Cai P, Jiang N, Wang H, Chen Q. Identification and characterization of microRNAs and endogenous siRNAs in Schistosoma japonicum. BMC Genomics 11, 55 (2010).
  MedlineGoogle Scholar
• 58 Jin X, Lu L, Su H et al. Comparative analysis of known miRNAs across platyhelminths. FEBS J. 280, 3944–3951 (2013).
  Medline CASGoogle Scholar
• 59 Lu SH, Yan XL, Li SW et al. [Prophylactic effect of artesunate against experimental infection of Schistosoma mansoni]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 22, 20–23 (2004).
  MedlineGoogle Scholar
• 60 Faghiri Z, Skelly PJ. The role of tegumental aquaporin from the human parasitic worm, Schistosoma mansoni, in osmoregulation and drug uptake. FASEB J. 23, 2780–2789 (2009).
  Medline CASGoogle Scholar
• 61 Pereira RV, Cabral FJ, Gomes MS et al. Molecular characterization of SUMO E2 conjugation enzyme. differential expression profile in Schistosoma mansoni. Parasitol. Res. 109, 1537–1546 (2011).
  MedlineGoogle Scholar
• 62 Pereira RV, Gomes Mde S, Cabral FJ et al. Up-regulation of SUMO E3 ligases during lung schistosomula and adult worm stages. Parasitol. Res. 113, 2019–2025 (2014).
  MedlineGoogle Scholar